Key facts
- This page summarizes Daniel B. Gilmer's Form 4 filing for Armata Pharmaceuticals, Inc. (ARMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Apr 2026, 16:24.
Daniel B. Gilmer - 24 Apr 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)
- Reporting relationship
- Director
- Issuer ticker
- ARMP
- Reported as of
- 24 Apr 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Daniel Gilmer
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Daniel B. Gilmer filed Form 4 for Armata Pharmaceuticals, Inc. (ARMP) on 28 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002122703
Primary reporting owner
Gilmer Daniel B.
- Relationship
- Director
- Address
- 5005 MCCONNELL AVENUE, LOS ANGELES
- Signature
- /s/ Daniel Gilmer
- Signature date
- 28 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARMP
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- Shares
- +51,280
- Change %
- Price
- $0.000000*
- Shares after
- 51,280
- Date
- 24 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,280
- Exercise price
- $12.92
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Stock Option vests as to one-third of the underlying shares of common stock on each of the first, second and third annual anniversaries of the date of grant, subject to continuous service through the vesting date.